arrow
A

Aditya H. Gaur

St Jude Children's Research Hospital
H指数:42
被引数:7,556

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Immune correlates analysis of antibody responses against SARS-CoV-2 variants in the ENSEMBLE vaccine efficacy trial

SARS-CoV-2变异株抗体反应的免疫相关性分析:ENSEMBLE疫苗有效性试验

2025-09-290
OAAI
Electronic Dose Monitoring Feedback (EMF) with Youth Living with HIV: Qualitative Exploration of Reactions to Viewing Dosing Calendars

电子剂量监测反馈(EMF)在青年HIV感染者中的应用:对查看剂量日历反应的定性探索

2025-07-210
OA
Pharmacokinetics, safety and efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in children with HIV aged from 2 years and weighing at least 14 kg

埃替拉韦/考比司他/恩曲他滨/替诺福韦艾拉酚胺在2岁及以上、体重至少14 kg的HIV儿童中的药代动力学、安全性与有效性

2025-01-300
OAAI
Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons
2024-11-272
PRE
Acceptability and tolerability of long-acting injectable cabotegravir or rilpivirine in the first cohort of virologically suppressed adolescents living with HIV (IMPAACT 2017/ MOCHA): a secondary analysis of a phase 1/2, multicentre, open-label, non-comparative dose-finding study
2024-04-016
OAAI
Safety and pharmacokinetics of oral and long-acting injectable cabotegravir or long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study
2024-04-016
OAAI
Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features
2024-03-112
OAAI
Prediction of Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infection by Quantitative Digital Polymerase Chain Reaction Normalized to International Units
2022-09-212
OAAI
PARIS and SPARTA: Finding the Achilles' Heel of SARS-CoV-2
MSPHERE
IF3.1
2022-06-2922
OAAI
Combining SJ733, an oral ATP4 inhibitor of Plasmodium falciparum, with the pharmacokinetic enhancer cobicistat: An innovative approach in antimalarial drug development
2022-06-016
OAAI
Host Predictors of Broadly Cross-Reactive Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern Differ Between Infection and Vaccination

针对新型冠状病毒 (SARS-CoV-2) 的广泛交叉反应抗体的宿主预测因子在感染和疫苗接种之间有所不同

2021-12-109
OAAI
An Assessment of Serological Assays for SARS-CoV-2 as Surrogates for Authentic Virus Neutralization
2021-10-3115
OAAI
Fixed-dose combination bictegravir, emtricitabine, and tenofovir alafenamide in adolescents and children with HIV: week 48 results of a single-arm, open-label, multicentre, phase 2/3 trial
2021-09-0114
PRE